No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / therapeutic use*
-
Dasatinib / therapeutic use*
-
Female
-
Fusion Proteins, bcr-abl / genetics*
-
Humans
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
-
Philadelphia Chromosome*
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
Fusion Proteins, bcr-abl
-
Dasatinib